Join us along with our good friend Nathan Cassin, Pharmacy Director at Holmes Murphy, while we discuss the compliant, noncompliant, and questionable Rx cost solutions that are out there. We’ll also discuss the current landscape of the regulation of the pharmacy industry both directly and indirectly through plans that we would have traditionally thought would have been exempt from such regulations due to ERISA preemption.
